Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS42001643EBVENSG00000167346.9protein_codingMMP26NoNo56547Q9NRE1
TVIS10013998HBVENSG00000167346.9protein_codingMMP26NoNo56547Q9NRE1
TVIS10043157HBVENSG00000167346.9protein_codingMMP26NoNo56547Q9NRE1
TVIS10059204HBVENSG00000167346.9protein_codingMMP26NoNo56547Q9NRE1
TVIS10059198HBVENSG00000167346.9protein_codingMMP26NoNo56547Q9NRE1
TVIS10059205HBVENSG00000167346.9protein_codingMMP26NoNo56547Q9NRE1
TVIS10059206HBVENSG00000167346.9protein_codingMMP26NoNo56547Q9NRE1
TVIS10059199HBVENSG00000167346.9protein_codingMMP26NoNo56547Q9NRE1
TVIS10059207HBVENSG00000167346.9protein_codingMMP26NoNo56547Q9NRE1
TVIS10059200HBVENSG00000167346.9protein_codingMMP26NoNo56547Q9NRE1
TCGA Plot Options
Drug Information
GeneMMP26
DrugBank IDDB00786
Drug NameMarimastat
Target IDBE0003701
UniProt IDQ9NRE1
Regulation Typeinhibitor
PubMed IDs10852638; 10669951
CitationsHeath EI, Grochow LB: Clinical potential of matrix metalloprotease inhibitors in cancer therapy. Drugs. 2000 May;59(5):1043-55.@@Belotti D, Paganoni P, Giavazzi R: MMP inhibitors: experimental and clinical studies. Int J Biol Markers. 1999 Oct-Dec;14(4):232-8.
GroupsInvestigational
Direct ClassificationSecondary alcohols
SMILESCNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C
Pathways
PharmGKBPA164748329
ChEMBLCHEMBL279785